Through analyses of the cancer genome, the Neurofibromatosis 2 (NF2) gene has been identified as one such gene that, when mutated, acts as a driver of mutations with the potential to promote the carcinogenesis of several cancers [6]. This evidence concerns the gene NF2 and cancer.